Watch: Delving into the data of people with chronic lymphocytic leukaemia (CLL)
4th Mar 2021
In this new video, we take a look into the lab at Professor Jim Allan's research, as he identifies two genes which could help predict who would benefit from early treatment of CLL.
Meet Professor Jim Allan, one of our brilliant researchers looking at genetic markers of people with chronic lymphocytic leukaemia (CLL).
He found changes in two genes that are powerful at predicting who has a more aggressive type of disease, and therefore when they might need treatment.
This understanding could help clinicians identify people who would benefit from early treatment to slow the progression of CLL.
Will you support our work?
Coronavirus has led to a sudden drop in income, putting our dream of funding the research that beats blood cancer under threat. If you’re able to donate, we need your support now more than ever.